SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001551152-21-000013
Filing Date
2021-04-30
Accepted
2021-04-30 07:44:56
Documents
16
Period of Report
2021-04-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abbv-20210430.htm   iXBRL 8-K 66235
2 EXHIBIT 99.1 abbv-20210331xexhibit991.htm EX-99.1 302351
8 abbvieimage1a531a.jpg GRAPHIC 15145
  Complete submission text file 0001551152-21-000013.txt   679078

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abbv-20210430.xsd EX-101.SCH 4991
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abbv-20210430_cal.xml EX-101.CAL 799
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abbv-20210430_def.xml EX-101.DEF 21869
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abbv-20210430_lab.xml EX-101.LAB 45394
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abbv-20210430_pre.xml EX-101.PRE 22690
9 EXTRACTED XBRL INSTANCE DOCUMENT abbv-20210430_htm.xml XML 32082
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 21873769
SIC: 2834 Pharmaceutical Preparations